Researchers develop new agent to help root out hypertension-causing tumor

The fluorine-based agent replaces an iodine-based agent developed decades ago at the University of Michigan.

July 13, 2022 5:00 AM

Jacob Dwyer, Justine Ross, Michigan Medicine

Researchers have developed a noninvasive method to identify a potential cause of hypertension with a drastic reduction in radiation exposure, a new study shows.

Around 10-15% cases of hypertension, or high blood pressure, are believed to be caused by excessive production of the hormone aldosterone, which affects the body's salt-water balance. This can be due to an adrenal adenoma, a tumor that causes irregular aldosterone production.

Like Podcasts? Add the Michigan Medicine News Break on Spotify, Apple Podcasts or anywhere you listen to podcasts.

The current testing for an adrenal adenoma is invasive, sampling the blood leaving the adrenal gland. For years, radiologists had used an iodine agent for measuring cholesterol uptake, the precursor to aldosterone, as a noninvasive alternative. This test was complicated by requiring patients to take steroids for a week prior to imaging and exposed them to high amounts of radiation.

A Michigan Medicine team led by Allen Brooks, Ph.D., an assistant research scientist, developed a new reagent that replaced the iodine with fluorine-18, a radioisotope commonly used in PET scans. They found that the method resulted in significantly less radiation exposure and could allow screening for hypertension-linked aldosterone adenomas. The paper is published in the Journal of Nuclear Medicine.

"This agent gives us a noninvasive way to find out if aldosterone is being produced abnormally, one that significantly limits the potential harm to our patients through decreased exposure to radiation and limiting of steroid use," said Benjamin Viglianti, M.D., Ph.D., senior author of the paper and associate professor of radiology at University of Michigan Medical School.

"Adrenal adenoma, if identified, can be removed surgically, which can cure people of their hypertension. This can help people with the disease by being deployed as a screening tool."

The original iodine agent used for imaging patients with adrenal aldosteronism was developed at University of Michigan in the 1970s. It was discontinued in the late 2000s due to federal regulations.

Researchers tested the fluorine-18 reagent in nine healthy subjects, finding it safe to use and effective at detecting stimulated hormone production through increased cholesterol uptake. The next step, they say, is to conduct a larger clinical trial analyzing patients with hypertension caused by excessive aldosterone production.

However, given cholesterol is found in other diseases, particularly the cardiovascular system, there is hope that this agent could have broader clinical applications.

"This work is a modern improvement of one of the imaging agents developed 50 years ago by Raymond Counsell, William Beierwaltes and a team here at the university," Brooks said. "The continued close collaboration between physician scientists and research chemists have enabled the translation of new diagnostic agents to improve our understanding of disease and hopefully improve patient outcomes."

Additional authors include: Wade P. Winton, B.S., Jenelle Stauff, B.S., Janna Arteaga, B.S., Bradford Henderson, B.S., Jeremy Niedbala, B.S., Peter J. H. Scott, Ph.D., all of Michigan Medicine

Paper cited: "Development of Fluorinated NP-59: A Revival of Cholesterol Utilization Imaging with PET," Journal of Nuclear Medicine. DOI: 10.2967/jnumed.122.263864

Live your healthiest life: Get tips from top experts weekly. Subscribe to the Michigan Health blog newsletter

Headlines from the frontlines: The power of scientific discovery harnessed and delivered to your inbox every week. Subscribe to the Michigan Health Lab blog newsletter

Featured News & Stories

Minding Memory

Greenspace and Late-Life Cognitive Decline

In this episode Matt and Lauren will speak with Dr. Marcia Pescador Jimenez, an Assistant Professor in the Department of Epidemiology at Boston University whose research focuses on understanding the relationship between exposure to green space and health outcomes (including hypertension and cognitive measures). Emerging research has shown that midlife risk factors may delay or even prevent the onset of dementia later in life - among these include physical activity and social interaction. It’s not a stretch to imagine how a person’s environment may impact behaviors such as physical activity. For instance, there are places that lack sidewalks and parks that make exercising exceedingly difficult. Among environmental epidemiologists, there is growing interest in understanding how the built and natural environment influence our behaviors that, in turn, influence our health. We encourage you to listen to this episode while on a walk outside!

woman touching back leaning forward in pain at desk light powder blue button down

Health Lab

Does virtual care mean low-value care? Study says no

The rise of telehealth has come with concerns that it could encourage use of low-value care that’s not needed. But a study suggests this hasn't happened.

Health Lab

4 times you might need an ultrasound and didn’t know

An article about ultrasounds and in what situations to use them in, provided by radiologists.

close up of yellow cells and blue greenish teal background

Health Lab

An ultrasound-activated hydrogel for steady, sustained drug delivery

Researchers have developed a new composite hydrogel capable of achieving sustained, zero-order drug release using ultrasound as a trigger.

woman pregnant laying back with doctor looking at paper work and her getting blood pressure measured

Health Lab

Sharp spike seen in emergency visits for life threatening pregnancy complication

Hypertensive disorders of pregnancy, the second leading cause of maternal deaths worldwide, may be sending a significantly higher number of pregnant people to the emergency department.

navy background with wavy thicker lines going through and blue brain that turns red and then fades and white dots in middle that half turn red

Health Lab

How the brain's inner chamber governs your state of consciousness

Investigators at Michigan Medicine, who are studying the nature of consciousness, have successfully used the drug to identify the intricate brain geometry behind the unconscious state, offering an unprecedented look at brain structures that have traditionally been difficult to study.

Global Footer Secondary Navigation